In two sequential studies, hematological and gastrointestinal toxicity rates were analyzed within DPYS and UPB1 genotypes in a cohort of 113 cancer patients (67 of whom experienced severe toxicity, and 46 with good tolerance to FP) and 69 non-cancer individuals. Here, UPB1 is linked to cancer.